Search

Date 2001 Author/Creator Furst, D

1. FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra). (1st June 2001)

Authors:
Schiff, M; Furst, D; Fleischmann, R; Macri, M; Joh, T; Edwards, CK; Davis, MW
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60(2001)Supplement 1
Page Start:
A469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial). (1st June 2001)

Authors:
Keystone, E; Weinblatt, ME; Weisman, M; Furst, D; Paulus, H; Birbara, C; Fischkoff, S; Chartash, EK
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60(2001)Supplement 1
Page Start:
A481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Issue 6 (1st June 2001)

Authors:
Binks, M; Passweg, J R; Furst, D; McSweeney, P; Sullivan, K; Besenthal, C; Finke, J; Peter, H H; van Laar, J; Breedveld, F C; Fibbe, W E; Farge, D; Gluckman, E; Locatelli, F; Martini, A; van den Hoogen, F; van de Putte, L; Schattenberg, A V N; Arnold, R; Bacon, P A
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60:Issue 6(2001)
Page Start:
577
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search